FDA product code · Cardiovascular · Class 2

DXF: Catheter, Septostomy

DXF is FDA's product code for "Catheter, Septostomy": a Class 2 device classified under 21 CFR 870.5175, reviewed by the Cardiovascular panel.

510(k) review time for DXF

Across 13 510(k) clearances under DXF decided from 2018-01-01 to 2026-10-06, the median was 30 days from FDA receipt to decision. Half took between 29 and 105 days, and 80% were decided within 107 days. These are past clearances, not a forecast for a new submission.

Days from FDA receipt to 510(k) decision, DXF, decisions 2018-01-01 to 2026-10-06 (n = 13)
Fastest26
25th percentile29
Median30
75th percentile105
80th percentile107
90th percentile127
Slowest212

Source: openFDA 510(k) records, snapshot of 2026-10-06 (openFDA data as of 2026-09-28). Compare 510(k) review times across all device types, see every code side by side in the Clearance Timeline Estimator, or browse the clearances themselves in PredicateScope.

DXF in the public FDA record

Records naming DXF, from openFDA (snapshot of 2026-09-15)
Device recalls10
GUDID device identifiers973

Counts of records, not of devices or events. Adverse event reports for DXF are in MAUDEScope, as counts with the query shown: MAUDE has no denominator, so a report count is not a rate and does not show that a device caused an event.

FDA-recognized standards that cite DXF

No FDA recognized consensus standard cites DXF by product code. Horizontal standards such as biocompatibility, sterilization and software standards can still apply.

Source: FDA Recognized Consensus Standards, snapshot of 2026-09-01. Search them all in the Consensus Standards Lookup.

Related product codes